Dupilumab

Red

Brand Name(s):Dupixent

Indication:Atopic Dermititis

Rationale:1,2,8

Considered:Sep-19

Review Date:Sep-24

Comments:
NICE TA534 Dupilumab is recommended as an option for treating moderate to severe atopic dermatitis in adults, only if the disease has not responded to at least 1 other systemic therapy, such as ciclosporin, methotrexate, azathioprine and mycophenolate mofetil, or these are contraindicated or not tolerated